Syncrosome Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
- (Upcoming)
Syncrosome General Information
Description
Operator of drug efficiency research platform intended to offer robust drug efficacy data and interpretation. The company's platform has developed and validated more than fifteen disease models both flexible and human-sized organizations can design and operate tailored experimental protocols to give appropriate answers, enabling drug discovery companies with relevant disease models to give relevant data.
Contact Information
Website
www.syncrosome.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
- Campus Luminy Luminy Entreprises CP 908
- 163, avenue de Luminy
- 13288 Marseille
- France
+33 04 00 00 00 00
Syncrosome Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | Upcoming | Generating Revenue | ||||
| 2. Merger/Acquisition | 24-Jul-2019 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Startup |
Syncrosome Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Richard Mitry | Founder, President & Co-Chief Executive Officer | ||
| Gilles Fadat MD | Co-Chief Executive Officer |
Syncrosome Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Syncrosome Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Grand Luminy | Accelerator/Incubator | 000 0000 | 000000 0 |